biotech · Major Depressive Disorder · Alzheimer's Disease · NMRA
Neumora Therapeutics
Neumora Therapeutics clinical programs — 5 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- copenhagen, DK
- Employees
- 18
- Programs
- 5
- Drugs
- 2
- Patents
- 6
Neumora Therapeutics projects
5 ClinicalTrials.gov programs sponsored by Neumora Therapeutics.
Neumora Therapeutics has 5 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
NMRA-335140
Neumora Therapeutics
Major Depressive Disorder
1 trial -
NMRA-335140
Neumora Therapeutics
Major Depressive Disorder
5 trials -
NMRA-335140-303
Neumora Therapeutics
Major Depressive Disorder
1 trial -
NMRA-335140 80 mg
Neumora Therapeutics
Major Depressive Episode Associated With Bipolar II Disorder
1 trial -
NMRA-323511
Neumora Therapeutics
Alzheimer's Disease
1 trial
Frequently asked questions
How many clinical projects does Neumora Therapeutics have?
5 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.